COVID-19 vaccine developed by Massachusetts based Biotechnology Company Moderna Inc. (MRNA) will be going for $25 to $37. This was revealed by the company’s Chief Executive Officer Stephane Bancel during an interview with German weekly Welt am Sonntag.
Since Moderna announced its 94.5% effective COVID-19 vaccine , the European Commission has been engaging the drug development and vaccine development company with an aim of striking a deal to get supply of the much needed vaccine.
An official from the European Union involved in the talks said they are trying to strike a deal whereby Moderna will supply them with millions of doses of the vaccine at price lower than $25 per dose.
“Nothing is signed yet, but we’re close to a deal with the EU Commission. We want to deliver to Europe and are in constructive talks,” said the CEO concerning striking a deal with the EU. Bancel further said probably in a couple of days they will reach an agreement for the vaccine with the EU.
As early as July the European Union was already engaging Moderna concerning its experimental test for the COVID-19 vaccine.
Bancel said the amount which they will be charging governments for the vaccine will be subject to the amount of doses ordered further saying the amount is at par with that of a shot flu.
“Our vaccine therefore costs about the same as a flu shot, which is between $10 and $50,” added Bancel.